TSXV - Free Realtime Quote CAD

VentriPoint Diagnostics Ltd. (VPT.V)

0.2100 0.0000 (0.00%)
As of 11:14 AM EDT. Market Open.
Loading Chart for VPT.V
DELL
  • Previous Close 0.2100
  • Open 0.2150
  • Bid 0.2100 x --
  • Ask 0.2150 x --
  • Day's Range 0.2100 - 0.2150
  • 52 Week Range 0.1200 - 0.3600
  • Volume 9,500
  • Avg. Volume 87,701
  • Market Cap (intraday) 32.933M
  • Beta (5Y Monthly) 0.40
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0300
  • Earnings Date May 2, 2024 - May 7, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. The company offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers; VMS+ software for use in creating three-dimensional model that generates accurate heart volumetric measurements. It also develops a suite of applications for various heart diseases and imaging modalities, including congenital heart disease, pulmonary hypertension, cardiotoxicity of chemotherapy treatments for cancer, and Covid-19 related heart issues. The company was incorporated in 2005 and is headquartered in Toronto, Canada.

www.ventripoint.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: VPT.V

Performance Overview: VPT.V

Trailing total returns as of 4/25/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

VPT.V
30.00%
S&P/TSX Composite index
4.20%

1-Year Return

VPT.V
40.00%
S&P/TSX Composite index
5.61%

3-Year Return

VPT.V
61.11%
S&P/TSX Composite index
14.32%

5-Year Return

VPT.V
61.54%
S&P/TSX Composite index
31.66%

Compare To: VPT.V

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: VPT.V

Valuation Measures

Annual
As of 4/24/2024
  • Market Cap

    32.93M

  • Enterprise Value

    31.06M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    917.52

  • Price/Book (mrq)

    25.06

  • Enterprise Value/Revenue

    865.42

  • Enterprise Value/EBITDA

    -6.65

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -63.46%

  • Return on Equity (ttm)

    -141.63%

  • Revenue (ttm)

    35.89k

  • Net Income Avi to Common (ttm)

    -4.74M

  • Diluted EPS (ttm)

    -0.0300

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2.3M

  • Total Debt/Equity (mrq)

    32.61%

  • Levered Free Cash Flow (ttm)

    -2.38M

Company Insights: VPT.V

People Also Watch